Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Superior Laryngeal Nerve Block for Neurogenic Cough
NCT04468542Phase 3Unknown
- Sponsor
- University of South Florida
- Start
- Jan 2021
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of bupivacaine, triamcinolone acetonide in cough, sponsored by University of South Florida. Status: unknown.
02
Drugs
bupivacainetriamcinolone acetonide
03
Conditions
cough
Beyond the preview
Go deeper on NCT04468542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04468542.